Living Cell Technologies Limited
Algorae Pharmaceuticals Limited, a pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand. The company's product pipeline includes AI-116, a novel combination drug candidate made up of donepezil and cannabidiol for the treatment of dementia, including Alzheimer's disease; AI-168, a novel combination drug candidate made up … Read more
Living Cell Technologies Limited (LVCLF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.000x
Based on the latest financial reports, Living Cell Technologies Limited (LVCLF) has a cash flow conversion efficiency ratio of 0.000x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-84.69) by net assets ($2.23 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Living Cell Technologies Limited - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Living Cell Technologies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Living Cell Technologies Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Living Cell Technologies Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
EPS Bio Technology Corp.
TWO:4183
|
-0.068x |
|
Carolina Rush Corporation
V:RUSH
|
N/A |
|
MainStreetChamber Holdings Inc.
PINK:MSCH
|
-0.226x |
|
Kumpulan H & L High-Tech Bhd
KLSE:7033
|
0.035x |
|
Fresh Grapes LLC
NYSE MKT:VINE
|
-0.396x |
|
AB Panevezio Statybos Trestas
STU:YK3
|
-0.069x |
|
Forza Land Indonesia Tbk PT
JK:FORZ
|
-0.016x |
|
PP PRIME Public Company Limited
BK:PPPM
|
-0.013x |
Annual Cash Flow Conversion Efficiency for Living Cell Technologies Limited (2004–2025)
The table below shows the annual cash flow conversion efficiency of Living Cell Technologies Limited from 2004 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $2.23 Million | $-785.00 | 0.000x | +99.93% |
| 2024-06-30 | $3.01 Million | $-1.52 Million | -0.505x | +4.28% |
| 2023-06-30 | $3.76 Million | $-1.99 Million | -0.528x | -4.31% |
| 2022-06-30 | $4.03 Million | $-2.04 Million | -0.506x | +52.31% |
| 2021-06-30 | $1.38 Million | $-1.46 Million | -1.061x | +1.77% |
| 2020-06-30 | $2.88 Million | $-3.11 Million | -1.080x | -124.63% |
| 2019-06-30 | $4.14 Million | $-1.99 Million | -0.481x | +3.88% |
| 2018-06-30 | $7.14 Million | $-3.57 Million | -0.500x | -11.63% |
| 2017-06-30 | $7.52 Million | $-3.37 Million | -0.448x | +19.40% |
| 2016-06-30 | $5.68 Million | $-3.16 Million | -0.556x | +20.52% |
| 2015-06-30 | $5.13 Million | $-3.59 Million | -0.700x | -7056.25% |
| 2014-06-30 | $8.43 Million | $-82.44K | -0.010x | -109.69% |
| 2013-06-30 | $13.25 Million | $1.34 Million | 0.101x | +158.23% |
| 2012-06-30 | $14.35 Million | $-2.49 Million | -0.173x | +79.53% |
| 2011-06-30 | $6.76 Million | $-5.72 Million | -0.847x | +9.92% |
| 2010-06-30 | $6.24 Million | $-5.86 Million | -0.940x | +8.93% |
| 2009-06-30 | $5.53 Million | $-5.70 Million | -1.032x | -112.47% |
| 2008-06-30 | $11.53 Million | $-5.60 Million | -0.486x | +87.71% |
| 2007-06-30 | $1.40 Million | $-5.54 Million | -3.951x | -4.21% |
| 2006-06-30 | $1.74 Million | $-6.61 Million | -3.791x | -95.05% |
| 2005-06-30 | $3.14 Million | $-6.09 Million | -1.944x | -302.54% |
| 2004-06-30 | $-1.33 Million | $-1.27 Million | 0.960x | -- |